FORMULATION DEVELOPMENT OF CR OFLAXACIN MATRIX TABLET AND THEIR IN-VITRO EVALUATION

Journal Title: Indo American Journal of Pharmaceutical Sciences - Year 2018, Vol 5, Issue 4

Abstract

Among the all sophisticated drug deliveries oral drug delivery is known as safest and most convenient rout of administration. DDS are formulated for rapid release, for CDD (Controlled Drug delivery and release) and for targeted drug delivery. Controlled delivery system is the system which deliver the active ingredient at a predetermined rate and time for the local or systemic effect for a definite period of time. Formulation and development of CR made possible by the polymers i.e is synthetic polymers and natural polymers. Eudragit is an Synthetic amorphous polymer, which is non absorbable, non-biodegradable, and non-toxic polymers. Ofloxacin is a synthetic antibiotic of the fluoroquinolone drug considered to be a second generation flouroquinolone.(12) (13) ofloxacin is approved for the treatment of bacterial infection like chronic bronchitis, community acquired pneumonia, acute pelvic inflammatory disease complicated urinary tract infection. In this study CR drug formulated of Ofloxacin by adding Xanthan Gum and Eudragit RL100 polymers with direct compression method. Pre-formulation studies were conducted which all were according to the standards. Three different drug and polymers ratios were incorporated of two different polymers i.e. 10.3, 10.4, 10.5. Invitro dissolution studies were also conducted, the %age release was enhanced in all formulation. The formulation 10.3 in both formulations enhanced the release rate more than the other formulations. These polymers can also be used in other drug preparations and also suitable for development of CR formulations which may extended the drug release.

Authors and Affiliations

Keywords

Related Articles

METHOD DEVELOPMENT, VALIDATION AND STABILITY INDICATING ASSAY PROCEDURE OF PREGABALIN BY USING RP-HPLC

A simple, rapid and precise Reverse phase liquid chromatographic method has been developed and subsequently validated for estimation of Pregabalin in tablet dosage form. The method is based on High Performance Liquid Chr...

ROLE OF HEALTH EDUCATION AND ENVIRONMENTAL MEDICAL ISSUES IN ELECTORAL PROCESS IN PAKISTAN

Objective: Research was held for the evaluation of wheatear health education and other environmental medical and social issues influence the electoral process in Pakistan. Study design: Exploratory quantitative and case...

DEVELOPMENT AND VALIDATION OF A STABILITY INDICATING RP-HPLC METHOD FOR THE DETERMINATION OF TERIZIDONE

A simple, rapid, sensitive, and linear stability indicating reverse phase HPLC method was developed for estimation of Terizidone. In this method separation was carried out on HiQSil C8 column (250mm*4.6 mm, 5μm) using Am...

ANTECEDENTS OF DENGUE VIRUS DURING THE CLINICAL INVESTIGATIONS IN FAISALABAD

Background: Dengue is the most important viral mutagenic disease in public health, caused by one of the four serotypes (DEN-1, 2, 3 and 4) of the dengue virus, a positive chain RNA virus of the Flaviviridae family, which...

EFFECTS OF ORTHODONTIC PAIN ON QUALITY OF LIFE OF PATIENTS UNDERGOING ORTHODONTIC TREATMENT IN PAKISTAN

Introduction: In orthodontics, researchers have assessed health-related quality of life (OHRQOL) in connection with orthodontic treatment outcomes; however, research on orthodontic patients QOL during their treatment is...

Download PDF file
  • EP ID EP280161
  • DOI -
  • Views 269
  • Downloads 0

How To Cite

(2018). FORMULATION DEVELOPMENT OF CR OFLAXACIN MATRIX TABLET AND THEIR IN-VITRO EVALUATION. Indo American Journal of Pharmaceutical Sciences, 5(4), 2572-2579. https://europub.co.uk/articles/-A-280161